Femasys (FEMY) EBIT Margin (2020 - 2026)
Femasys' (FEMY) quarterly EBIT Margin came in at 1526.66% in Q2 2026, down 58557.0% on a YoY basis from N/an in Q2 2025, and down 62.22% quarter-over-quarter from 941.09% in Q2 2025.
Powered by 
Analysis
Femasys (FEMY) EBIT Margin (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported EBIT Margin for 7 consecutive years, with 1526.66% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin fell 58557.0% year-over-year to 1526.66%; the trailing twelve-month figure through Jun 2026 stood at 1147.92% (down 13292.0% YoY), and the FY2025 full-year result was 766.95%, up 32480.0% from the prior year.
- EBIT Margin slipped to 1526.66% in Q2 2026 per FEMY's latest filing, from 941.09% in the prior quarter.
- Across five years, EBIT Margin topped out at 812.03% in Q4 2024 and bottomed at 2087.89% in Q4 2023.
- Historically, EBIT Margin has averaged 1249.8% across 5 years, with a median of 1034.64% in 2023.
- The widest YoY moves for EBIT Margin: up 127586 bps in 2024, down 110767 bps in 2024.
- Over 5 years, EBIT Margin stood at 1280.87% in 2022, then slumped by 63 bps to 2087.89% in 2023, then jumped by 61 bps to 812.03% in 2024, then dropped by 16 bps to 941.09% in 2025, then tumbled by 62 bps to 1526.66% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 1526.66%, 941.09%, and 1600.11% for Q2 2026, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 19.15% |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | -1,526.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,526.66% |
| Jun 30, 2025 | -941.09% |
| Mar 31, 2025 | -1,600.11% |
| Dec 31, 2024 | -812.03% |
| Sep 30, 2024 | -922.39% |
| Jun 30, 2024 | -2,023.69% |
| Mar 31, 2024 | -1,277.07% |
| Dec 31, 2023 | -2,087.89% |
| Sep 30, 2023 | -1,670.18% |
| Jun 30, 2023 | -916.02% |
| Mar 31, 2023 | -1,034.64% |
| Dec 31, 2022 | -1,280.87% |
| Sep 30, 2022 | -879.88% |
| Jun 30, 2022 | -877.55% |
| Mar 31, 2022 | -896.92% |
| Dec 31, 2021 | -927.05% |
| Sep 30, 2021 | -835.16% |
| Jun 30, 2021 | -583.14% |
| Mar 31, 2021 | -553.88% |
| Dec 31, 2020 | -592.41% |